Skip to main content

Table 1 Baseline characteristics of 651 overweight or obese subjects without a history of diabetes

From: Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome

  All Men Women P
Number of cases 651 193 458  
Age (years) 43 ± 13 46 ± 12 42 ± 13 0.03
Weight (kg) 109.3 ± 21.2 124.5 ± 22.1 102.4 ± 17.2 < 0.01
BMI (kg/m2) 38.2 ± 6.1 39.0 ± 6.4 37.9 ± 5.9 0.02
Waist circumference (cm) 116.2 ± 14.8 126.3 ± 12.6 112 ± 13 < 0.01
Systolic BP (mmHg) 129 ± 15 133 ± 14 127 ± 15 0.02
Diastolic BP (mmHg) 76 ± 11 80 ± 11 75 ± 10 0.03
Triglycerides (mg/dl) 132 (97–185) 163 (114–220) 125 (91–170) < 0.01
Total cholesterol (mg/dl) 198 (175–227) 189 (167–219) 203 (177–230) < 0.01
HDL cholesterol (mg/dl) 49 (40–60) 42 (35–50) 52 (44–63) < 0.01
CT visceral fat (cm2) 183 (131–249) 249 (194–315) 157 (113–209) < 0.01
CT subcutaneous fat (cm2) 593 ± 145 562 ± 167 605 ± 132 < 0.01
CT total fat (cm2) 789 ± 173 820 ± 189 775 ± 164 < 0.01
Fasting glucose (mg/dl) 86 (80–95) 92 (84–101) 84 (79–92) 0.01
2-h OGTT glucose (mg/dl) 140 (118–167) 147 (125–185) 138 (117–161) < 0.01
HbA1c (%) 5.5 (5.3–5.8) 5.6 (5.4–6.0) 5.4 (5.2–5.7) 0.03
HbA1c (mmol/mol) 37 (34–40) 38 (36–41) 36 (33–37) 0.03
FINDRISC score 12 ± 4 13 ± 4 12 ± 4 0.54
HOMA-S 3.3 (2.1–5.4) 4.5 (2.9–7.0) 3.0 (1.8–4.6) < 0.01
HOMA-B (%) 243 (153–375) 241 (153–361) 247 (157–380) 0.65
Microalbuminuria (μg/min) 8.0 (5.9–13.0) 9.0 (7.0–16.0) 8.0 (5.0–12.0) 0.01
  1. Data are expressed as mean ± standard deviation or median (range)
  2. BMI body mass index, BP blood pressure, HDL high density lipoprotein, OGTT oral glucose tolerance test, HOMA-S homeostasis model assessment of insulin resistance, HOMA-B homeostasis model assessment of beta-cell function